TY - JOUR ID - 13468 TI - The efficacy of camel milk and Tarangabin (manna of Alhagi maurorum( combination therapy on glomerular filtration rate in patients with chronic kidney disease: A randomized controlled trial JO - Avicenna Journal of Phytomedicine JA - AJP LA - en SN - 2228-7930 AU - Hosseini, Seyed Mousa Alreza AU - Anushiravani, Majid AU - Mojahedi, Mohammad Javad AU - Hami, Maryam AU - Zibaee, Saeid AU - Rakhshandeh, Hasan AU - Taghipour, Ali AU - Nikakhtar, Zahra AU - Eshraghi, Hamid AU - Tavassoli, Amir Parviz AD - Department of Gastroenterology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran AD - Department of Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran AD - Kidney Transplantation Complications Research Center, Ghaem Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran AD - Kidney Transplantation Complications Research Center, Ghaem Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran AD - Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Mashhad, Iran AD - Pharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran AD - Department of Epidemiology and Biostatistics, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran. AD - Department of Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Y1 - 2020 PY - 2020 VL - 10 IS - 2 SP - 170 EP - 180 KW - Camel milk KW - Tarangabin (Manna of Alhagi. maurorum) KW - Traditional Persian Medicine KW - Chronic kidney disease (CKD) KW - Glomerular filtration rate (GFR) KW - Randomized controlled trial DO - 10.22038/ajp.2019.13468 N2 - Objective: This study was designed to investigate the effect of camel milk and Tarangabin (manna of Alhagi maurorum) combination therapy in addition to conventional treatments in patients with chronic kidney disease (CKD).  Material and Methods: Forty-four patients of 15 to 70 years old, with CKD due to hypertension or diabetes, and estimated glomerular filtration rate (eGFR) of 15–60 ml/min per 1.73 m2, were enrolled in this trial. The patients were randomized to receive either 400 cc of camel milk with 10 cc of Tarangabin syrup orally in two divided daily doses for 3 months plusconventional therapy or conventional therapy alone. The conventional treatment included diabetes medications and angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Results: The baseline characteristics of patients were similar in the two groups. Serum levels of creatinine (p=0.01), blood levels of urea nitrogen (p=0.0001), triglyceride (p=0.02), and potassium (p=0.05), and diastolic blood pressure (p=0.0001) decreased, while eGFR (p=0.001) improved in intervention group significantly. Conclusion: It seems that the therapeutic protocol used in this study can improve renal function in patients with CKD through regulating glucose and anti-inflammatory, laxative, and immunostimulatory properties. UR - https://ajp.mums.ac.ir/article_13468.html L1 - https://ajp.mums.ac.ir/article_13468_d9afe57e62bd1adef0144a98818310e9.pdf ER -